Antiplatelet Cinnarizine Powder Cinnarizine Material Cinnarizine/Stugeron

China Antiplatelet Cinnarizine Powder Cinnarizine Material Cinnarizine/Stugeron, Find details about China Cinnarizine, Cinnarizine Powder from Antiplatelet Cinnarizine Powder Cinnarizine Material Cinnarizine/Stugeron

Basic Info.

Model NO.

Condavo-Cinnarizine

Name

Cinnarizine

Product Name

Cinnarizine Powder

Appearance

White Powder

Color

White Color

Test Method

HPLC UV

Storage

Cool Dry Place

Shelf Life

2 Years

Assay

99%

Grade

Medicine Grade

COA

Available

CAS

21172-43-0

C11h13f3o3s

282.277

Density

1.305

Boiling Point

365.9

Trademark

Condavo

Transport Package

1kg/ Aluminium Bag or 25kg/Drum; as Required

Specification

99%

Origin

Shaanxi

Model NO.

Condavo-Cinnarizine

Name

Cinnarizine

Product Name

Cinnarizine Powder

Appearance

White Powder

Color

White Color

Test Method

HPLC UV

Storage

Cool Dry Place

Shelf Life

2 Years

Assay

99%

Grade

Medicine Grade

COA

Available

CAS

21172-43-0

C11h13f3o3s

282.277

Density

1.305

Boiling Point

365.9

Trademark

Condavo

Transport Package

1kg/ Aluminium Bag or 25kg/Drum; as Required

Specification

99%

Origin

Shaanxi

Product Desciption

Antiplatelet Cinnarizine powder Cinnarizine Material Cinnarizine/Stugeron

Antiplatelet Cinnarizine Powder Cinnarizine Material Cinnarizine/Stugeron

Product Name	Cinnarizine
CAS	21172-43-0
Appearance	White crystalline powder
MF	C11H13F3O3S
MW	282.277
Purity	99%
Shelf Life	2 Years

Cinnarizine is a medication derivative of piperazine, and characterized as an antihistamine and a calcium channel blocker, it is also known to promote cerebral blood flow, and so is used to treat cerebral apoplexy, post-trauma cerebral symptoms, and cerebral arteriosclerosis. However, it is more commonly prescribed for nausea and vomiting due to motion sickness or other sources such as chemotherapy, vertigo, or Ménière's disease. Cinnarizine was first synthesized by Janssen Pharmaceutica in 1955. The nonproprietary name is derived from the cinnamyl substituent on one of the nitrogen atoms, combined with the generic ending "-rizine" for "antihistaminics/cerebral (or peripheral) vasodilators". It is not available in the United States or Canada. It is manufactured and marketed in Bangladesh under the trade name Suzaraon by Rephco Pharmaceuticals Limited. It has also been cited as one of the most used drugs for seasickness within the British Royal Navy.

Antiplatelet Cinnarizine Powder Cinnarizine Material Cinnarizine/Stugeron

Antiplatelet Cinnarizine Powder Cinnarizine Material Cinnarizine/Stugeron 1. Treatment of cytomegalovirus retinitis during induction and maintenance in immunodeficiency patients.
2. Prevention of cytomegalovirus infection in patients receiving organ transplantation and prevention of cytomegalovirus disease in AIDS patients with cytomegalovirus positive serum test.
Antiplatelet Cinnarizine Powder Cinnarizine Material Cinnarizine/Stugeron

It is used for the treatment of cerebral thrombosis, cerebral embolism, cerebral arteriosclerosis, cerebral hemorrhage recovery period, subarachnoid hemorrhage recovery period, sequelae of brain trauma, inner ear vertigo, coronary arteriosclerosis and diseases caused by poor peripheral circulation. In recent years, it has been reported that this product can be used for chronic urticaria, senile pruritus and other allergic skin diseases.

Antiplatelet Cinnarizine Powder Cinnarizine Material Cinnarizine/Stugeron